With LPWAN low-power wide-area networks such as NB-IoT and LoRa, and the current 5G network construction in full swing, it carries the vision of the Internet of Everything, and solves the needs of large-scale deployment of the Internet of Things, such as low power consumption and long-distance connection. According to data, LPWAN connection is in 2018. The compound annual growth rate until 2023 is 109%, which will open up the trillion-dollar IoT market and promote the application of IoT in vertical fields such as industry, energy, retail, logistics and traceability.
The new economy benefits from IoT technology and promotes industry transformation and upgrading
In recent years, the rapid development of China's new economy has exceeded expectations. Mobile payment, big data, and cloud computing have driven industrial revolution and product innovation. China has become the most innovative and dynamic market in the world today. The vigorous development of the new economy has unleashed potential for the development of innovative enterprises centered on the Internet of Things, artificial intelligence and biotechnology, and is expected to expand rapidly. So far, all walks of life are actively preparing for the development opportunities released by the new economy.
Looking at the world, the transformation enterprises with AI + IoT as the core have developed rapidly. At the same time, with the integration of biotechnology, artificial intelligence, the Internet of Things and other technologies, there are unprecedented opportunities for biotechnology innovation companies. Innovative companies including Haier Biomedical have emerged, using new technologies such as the Internet of Things to boost intelligent biology The advent of the age of technology.
Among them, Haier Biomedical, relying on biotechnology cryogenic storage and core technology innovation, has actively transformed to the Internet of Things technology in the past year, and achieved breakthrough success. In the fields of blood safety, vaccination safety, biological sample bank, etc., use Internet of Things technology to improve the intelligence level of products and equipment, vigorously promote the integration of new generation information technology, Internet of Things technology and medical equipment manufacturing industry, and provide products including a new generation of things The integrated solution of IoT biotechnology, including networked cryogenic storage devices, is the industry-leading definition of the intelligent IoT scenario in the biomedical device industry.
Under the wave of the Internet of Things, Haier's biomedical innovation technology protects health
In the future, the combination of biotechnology and big data will be regarded as the next technology trend. Compared with international giants such as Apple and Google, which transform the medical and health field and use personal wearable devices to protect people's health, Haier Biomedical uses Internet of Things technology. Transform the industry. Zhou Yunjie, President of Haier Group, said in the "Dialogue Entrepreneurs" column of the guest network that as a responsible enterprise, it should take advantage of its own technological advantages and take the idea of the Internet of Things to undertake greater social responsibilities and solve more social problems. question.
In practical application cases, for example, Haier Biomedical and the Affiliated Hospital of Qingdao University have co-created and cooperated to create a smart blood safety solution for the Internet of Things. Through RFID radio frequency technology, information such as blood information and storage location can be identified in real time, and uploaded to the blood The management platform can quickly and accurately remove the required blood. This transformation has upgraded the centralized blood management of the blood transfusion department to a distributed IoT contact management, using big data, cloud computing and IoT technologies to transform the originally isolated blood resources into a broader regional blood sharing scheme.
The clinical application effect is obvious. The blood collection is reduced from 20 minutes to 1 minute, which saves valuable time for saving lives. It can also return unused blood, and realize the sharing of blood information and blood between different hospital districts and different hospitals. Resource allocation, creating a new revolution in the Internet of Things for clinical blood use in China.
In the field of vaccination safety, Haier Biomedical has co-created and cooperated with Tianjin Dawangzhuang Street Community Health Service Center to create an IoT smart vaccination solution to solve the "last mile" traceability of vaccination, and the vaccine refrigerators in the cold chain room have passed the Connected with the vaccination information system, each vaccination box is an IoT contact point, which realizes the traceability management of vaccines, supervises single vaccines, reduces vaccination errors, realizes the whole-process guarantee of vaccine safety, and improves vaccination management at the same time. efficiency.
Under the wave of the Internet of Things, Haier Biomedical has made breakthroughs in the field of Internet of Things biotechnology, creatively reorganized and created a new generation of Internet of Things inoculation boxes, Internet of Things blood coolers and other Internet of Things biotechnology innovative products, providing security for everyone's entire life cycle. Effective and convenient health services, and become the first transformation of the Internet of Things + biotechnology innovation.
At last
After the application of technologies such as the Internet of Things, artificial intelligence and big data in biotechnology, such innovative companies will usher in explosive development. Haier Biomedical is actively transforming into the Internet of Things technology based on this trend, and my country has a huge population base. , the market scale of the medical industry has gradually increased, and the rapid development of biomedical care has been promoted. The scale of China's biotechnology integrated solutions market reached 103.5 billion in 2017 and is expected to reach 272.6 billion from 2022 to 2027, according to the Frost & Sullivan report.
From the perspective of the industry, with the continuous advancement of the "Healthy China" strategy, Haier Biomedical's innovative measures to create a global IoT biotechnology brand will set off unpredictable changes in the field of biotechnology, and its development potential is bound to endow the industry development. Boundless extension.
English
